Order Cheap Gleevec Online

Posts Tagged ‘Blackboard’

Published on May 27, 2010 by R "Ray" Wang

The majority of 21 publicly traded software vendors managed to show year-over-year (YoY) gains over the dismal beating from calendar year (CY) Q1 2009. SaaS vendor maintained their double digit gains while on-premise vendors mostly showed positive traction (see Figure 1) and (see Figure 2). Highlights for the 2010 CY Q1 2010 results:

Big gains in YoY license revenue for on-premise vendors such as Manhattan Associates (188.64%) and JDA (87.43%) reflect the investments being made in retail and supply chain. Manhattan's gains are the greatest across the board as they demonstrate a turnaround from last year.

Order cheap gleevec online, Meanwhile, SMB bell-weathers Lawson (28.10%), Deltek (24.75%), and Epicor (23.21%) signal return of key license sales in on-premise. Concurrently, Oracle (20.45%) and SAP (11.oo%) demonstrate a strong recovery in enterprise license revenue growth in on-premise.

Maintenance fee growth for on-premise vendors hold steady with mostly single digit YoY gains except JDA Software (32.71%) and SAP (11.34%).

SaaS vendors kept steady growth in the double digits for subscription revenue. Purchase gleevec, UltimateSoftware (27.80%), RightNow (26.80%), Pennsylvania PA Penn., Washington WA Wash., Salesforce.com (24.47%), and SuccessFactors (24.29%) led the charge.

Overall growth rates on a YoY revenue basis have stabilized for most SaaS vendors at the mid teens to twenties.

Of interesting note, ordering iressa, Købe epogen online, professional services fees for on-premise vendors match or double the license revenue. SaaS vendor professional services revenue are well below 1x license revenues, zometa online kaufen, Kaufen evista, closer to 10% or less.


Figure 1. Software Insider Index® On Premise Vendors: Q1 CY 2010


(Right click to view full image)
Copyright © 2010 R Wang and Insider Associates, LLC, Kaufen arimidex. Köpa evista online, All rights reserved.

Figure 2. Software Insider Index® SaaS Vendors: Q1 CY 2010


(Right click to view full image)
Copyright © 2010 R Wang and Insider Associates, comprar zometa barato, Lowest price epogen, LLC. All rights reserved.
The Bottom Line - Recovery In Sight Means Lower Discounts In Enterprise Contracts

Good news - new license sales indicate a recovery! Bad news - recovery will mean less discounting in non-competitive renewals. Recent deals indicate that competitive deals in both Enterprise and SMB show that vendors will continue to compete for business. Pricing pressures from the SaaS vendors drive most of the discounting in renewal deals. However, should the recovery continue, expect less concessions in maintenance fee discounts, financing options, maintenance fee price increases, and flexibility in contract policies, order cheap gleevec online.

Your POV.

Have you found a change in how your vendor deals with you? Is SaaS influencing how you buy? Feel free to post your comments or send a message to rwang0 at gmail dot com or r at softwareinsider dot org and we’ll keep your anonymity, Køb discount arimidex. New Jersey NJ N.J., Please let us know if you need help with your apps strategy efforts. Here’s how we can help:

Providing contract negotiations and software licensing support

Evaluating tech projects for business value

Assessing apps strategies (e.g. single instance, buy arimidex cheap, Epogen without a prescription, two-tier ERP, upgrade, cheap epogen online, αγοράζουν φτηνά zometa, custom dev, packaged deployments”

Designing end to end processes and systems

Comparing SaaS/Cloud integration strategies

Assisting with legacy ERP migration

Planning upgrades and migration

Performing vendor selection

Disclaimers

* Not responsible for any math errors or erroneous revenue information, ordering cytoxan online cheap. Where to buy cheap arimidex, 1. Order cheap gleevec online, Calendar year estimates based on the quarter nearest the calendar year.

2, Osta casodex. Cheap epogen online legally, Why these vendors than others? Easy – because I cover them.

3, Maine ME Me.. Ohio OH, Exchange rates as of February 25th, 2010 for vendors who have not published quarterly conversions. Not responsible for currency flux, Missouri MO Mo..

4, order cheap gleevec online. Casodex online store, Estimates created for privately held vendors, when listed.

Not sure. Please read the quarterly filings yourself =)

Related resources and links

Software Insider Index™ (SII): 2009 SII Top 35 Enterprise Business Apps Vendors™

2009 Calendar Year Q4

2009 Calendar Year Q3

2009 Calendar Year Q2

2009 Calendar Year Q1

Software Insider Index™ (SII): 2008Software Insider Index^TM (SII): SII Top 30 Enterprise Business Apps Vendors^TM & SII Top SaaS Business Apps Vendors^TM SII Top 30 Enterprise Business Apps Vendors™

2008 Calendar Year Q4

2008 Calendar Year Q3

2008 Calendar Year Q2

2008 Calendar Year Q1

.

Order Casodex

Published on March 18, 2010 by R "Ray" Wang

2009 Results In Major Revenue Declines For On Premise And Officially The Year Of SaaS Order casodex, A review of last year's financial performance should erase any doubts about the viability of SaaS as a deployment option and a business model. Traditional on-premise business apps vendors took the brunt of the beating earlier in the year but have slowly recovered, acheter evista. Acquistare online gleevec, This year's Software Insider Index™ (SII) highlights two major themes:

Legacy On-Premise Vendors Retain Operating Margins But Lose Revenue Share. Almost every on-premise software vendor lost revenue on a year-over-year (YoY) basis in 2009 (see Figure 1). IFS (3.87%) and SAS Institute (2.21%) grew in the midst of the financial onslaught. SAP is still double the size of Oracle in apps revenue! Vendors such as QAD (-31.42%) and Manhattan Associates (-26.84%)saw the worst YoY declines (see Figure 2). Most vendors relied on their maintenance and support to bolster their revenues. For example, South Carolina SC S.C., Maine ME Me., CDC, Epicor, discount gleevec, Buy casodex, Exact, Lawson, iressa no prescription, Purchase arimidex online, Manhattan, Oracle, billige zometa apotek, Cheap evista, QAD, and SAP exceeded a 1:2 ratio in new license to maintenance revenue. Why? Customers chose not to upgrade, arimidex price, Billig capecitabine apotek, purchase new licenses, and expand their footprint, Jotta evista verkossa. Cytoxan generic, Despite the downturn, most vendors survived with operating margins between 10% an 50%, gleevec online kopen, Delaware DE Del., well above those achieved by SaaS vendors. Traditional vendors clearly felt pressure from SaaS/Cloud.

SaaS Models Prove Themselves In 2009. Meanwhile, every SaaS vendor grew, cheap capecitabine no prescription, Order evista online, from Ariba with the lowest YoY revenue growth (0.44%) to SuccessFactors with the highest (38.73%). Overall the SaaS vendors tracked in the 2009 SII grew 7.98% in YoY revenue, order casodex. SaaS deployments expanded in all areas from CRM to HCM to spend management, Ohio OH. Evista pharmacy, Of note, Salesforce.com exceeded the $1.3B mark, evista generic, Buy iressa, a milestone for the SaaS industry.

Figure 1. Software Insider Index^TM (SII) Top 35 Enterprise Business Apps Vendors^TM (Calendar Year Revenue)

[caption id="attachment_4542" align="alignnone" width="702" caption="Copyright © 2010 R Wang and Insider Associates, buy arimidex without prescription, αγοράζουν φτηνά iressa, LLC. All rights reserved."][/caption]

Figure 2, pharmacy arimidex. Software Insider Index^TM (SII) Top 35 Enterprise Business Apps Vendors^TM (YOY Revenue Growth)
Order casodex, [caption id="attachment_4555" align="alignnone" width="704" caption="Copyright © 2010 R Wang and Insider Associates, LLC. All rights reserved."][/caption]

Your POV.

What's your read on the market? Do you feel the SaaS model has added pressure to your traditional vendors? Will everyone have a SaaS option in 2010.

Am I missing a vendor? Got the numbers wrong. Feel free to post your comments here or send me an email at rwang0 at gmail dot com .

Disclaimers

* Not responsible for any math errors or erroneous revenue information.

1, order casodex. Calendar year estimates based on the quarter nearest the calendar year.

2. Why these vendors than others? Easy - because I cover them.

3. Order casodex, Exchange rates as of February 25th, 2010 for vendors who have not published quarterly conversions. Not responsible for currency flux.

4. Estimates created for privately held vendors.

Not sure. Please read the quarterly filings yourself =)

Related resources and links

Take the new and improved survey on 3rd party maintenance

2009 Calendar Year Q4

2009 Calendar Year Q3

2009 Calendar Year Q2

2009 Calendar Year Q1

Software Insider Index™ (SII): 2008Software Insider Index^TM (SII): SII Top 30 Enterprise Business Apps Vendors^TM & SII Top SaaS Business Apps Vendors^TM SII Top 30 Enterprise Business Apps Vendors™

2008 Calendar Year Q4

2008 Calendar Year Q3

2008 Calendar Year Q2

2008 Calendar Year Q1

Buy Casodex Without Prescription

Published on February 24, 2010 by R "Ray" Wang

Buy casodex without prescription, The Year Of SaaS Shows... And Yes, North Dakota ND, Epogen online, In This Economy.

The recession continued to take its toll on software sales with a slight impact to the SaaS vendors. Growth rates have come down from the high 30's to the low 20's. But with "flat" the new growth metric in this down economy, osta alennus capecitabine, Wyoming WY Wyo., SaaS vendor results remain impressive. On the other hand, traditional on-premises vendors see some light at the end of the tunnel. License revenues have started to stabilize on a year-over-year basis. Major events in the 2009 Calendar Year (CY) Q4 include:

In YoY quarterly revenue growth, generic evista, Cytoxan pharmacy, Taleo (23.29%) led the pack followed by SalesForce (22.26%), and Blackboard (17.66%) (see Figure 1).

Salesforce.com achieves $1.4B in revenues for CY 2009. As the biggest SaaS vendor in the market, købe epogen online, Order cytoxan online legally, Salesforce.com is bigger than Microsoft Dynamics, Lawson, Køb discount arimidex, North Dakota ND, and Unit 4 (Agresso). To put this in perspective, Salesforce.com's revenue alone is at the size of all the other public SaaS vendors listed in the Software Insider Index.

Most on-premises vendors stabilized declines in new license revenue (see Figure 2). Keep in mind that on-premises vendors have remained profitable in this downturn. Maintenance continues to provide a cash cushion for most on-premises vendors.

License revenues versus maintenance revenues for some vendors such as Deltek, order capecitabine online legally, Cheap capecitabine without prescription, Epicor, Exact, iressa generic, Casodex discount, JDA Software, Lawson Software, Um zometa online, Epogen online store, Manhattan Associates, and Oracle reach or exceed 1:2 ratios. The result - lagging growth in acquiring new customers on latest releases.

IFS leads with a (21.38%) gain on YoY license revenue with Manhattan (3.21%), West Virginia WV W.Va., Købe gleevec online, Epicor (2.32%), and Oracle (1.92%) following with positive license revenue for calendar year Q4

Figure 1. Most SaaS Vendors Continue Break Neck Growth

Figure 2, online gleevec. Buy arimidex cheap, Many On Premises Vendors Rely On Maintenance To Bolster Sagging License Revenues

The Bottom Line - Clients Now Expect On-Premises Vendors To Have A "SaaS" Option

As we tally up the winners and losers for 2009, SaaS vendors have shown to the industry what's required for success in today's tough economic condition. The secret to their success transcends subscription pricing, zometa discount, Casodex, cloud services, rapid levels of innovation, Om zometa online, Nebraska NE Nebr., and point solutions. In fact, the success in SaaS comes from the attention to the relationship and the willingness to take a customer friendly stance. On-premises vendors who have delivered on a partnership with their customers have known this for years. However, αγοράσετε arimidex, they risk being consumed by the new business models of SaaS and Cloud. Customers expect their vendors to deliver hybrid options; and private and public clouds. Expect on-premises vendors without a Cloud deployment option to fade away in this decade as they become the legacy vendors they replaced in the client/server and Internet eras.

Your POV.

As an end user, have you seen the pace of SaaS adoption increase in your organization? Do you continue SaaS solutions with the same level of comfort as on-premises. As a software vendor, do you feel you have the right go-to-market cloud strategy for 2010. Please let us know if you need help with your enterprise apps strategy by:

Develop your SaaS apps strategy

Assist with SaaS contract strategies and the Customer Bill of Rights: SaaS

Improving innovation via SaaS and other deployment options

You can post or send on to rwang0 at gmail dot com or r at softwaresinsider dot org and we’ll keep your anonymity.

* Not responsible for any math errors or erroneous revenue information. Calendar year estimates based on the quarter nearest the calendar year. Exchange rates as of February 24th, 2010. Not responsible for currency flux. Please read the quarterly filings yourself =)

Related resources and links

Take the new and improved survey on 3rd party maintenance

2009 Calendar Year Q3

2009 Calendar Year Q2

2009 Calendar Year Q1

2008 Calendar Year Q4

2008 Calendar Year Q3

2008 Calendar Year Q2

2008 Calendar Year Q1

Order Iressa Online Cheap

Published on November 18, 2009 by R "Ray" Wang

Order iressa online cheap, Purchasing in Q3 reflected both economic downturn and summer doldrums. While on-premise vendors continued massive double digit declines in year-over-year new license revenue, SaaS vendors faced some pressures in keeping up with tremendous growth. However, long term economic outlook still favor SaaS players and early indications on Q4 budget flush indicate that SaaS and Cloud are top of mind. Major themes in the 2009 Calendar Year Q3 include:

On the SaaS front, Salesforce.com (19.55%) continues to lead the pack followed by Blackboard (18.44%) and Concur at (12.94%) (see Figure 1). While SaaS vendors still experienced growth, Concur (12.94%), Ultimate Software (9.76%), and Taleo (8.77%), NetSuite (3.22%) experienced drops in rate of growth. Taleo and NetSuite faced the biggest drops in Q3.

Tracked publicly traded SaaS vendors represented $756.2M in Q3 software revenues.

On-premise vendors showing gains in EPS despite revenue drops (see Figure 2).

Specialty on-premise vendors JDA Software (-2.63%) and IFS (-5.07%) reversed license growth and lost year-over-year quarterly gains.

Lawson Software reversed a license free fall showing growth in Q3 (22.77%). Ordering cytoxan pill, Healthcare and HCM continued to bolster its license growth and come back.

Maintenance revenues continue to float losses in license revenue for on-premise vendors. Growth in maintenance continues to slow.

Figure 1. SaaS Vendors Face Q3 Headwinds And Growth Slows Vs Q2

2009 Q3 Calendar Year SaaS Revenues

[caption id="attachment_3742" align="alignnone" width="789" caption="2009 Q3 Calendar Year SaaS Revenues - Copyright © 2009 R Wang and Insider Associates, Florida FL Fla., Order cytoxan online, LLC. All rights reserved."]
[/caption]

2009 Q2 Calendar Year SaaS Revenues

[caption id="attachment_3743" align="alignnone" width="798" caption="2009 Q2 Calendar Year SaaS Revenues - Copyright © 2009 R Wang and Insider Associates, iressa farmacia a buon mercato, Zometa no prescription, LLC. All rights reserved."]
[/caption]

Figure 2. On-premise Vendors Face Continued Market Brutality

[caption id="attachment_3746" align="alignnone" width="934" caption="2009 Q3 Calendar Year On-Premise Revenues - Copyright © 2009 R Wang and Insider Associates, lowest price gleevec, Kansas KS Kans., LLC. All rights reserved."][/caption]

The Bottom Line For Users - Expect Continued Discounts in Q4

A poor Q3 will bring good news to buyers in Q4 as vendors will continue to heavily discount licenses and professional services while delivering more value to retain maintenance margins. Conversations with 41 CIO's indicate that a Q4 budget flush is in the works. The conditions favor end users as poor economic conditions, Missouri MO Mo., Washington WA Wash., realization by vendors, and need to invest will yield a great buying season, Jotta gleevec verkossa. Buy iressa online cheap,

The Bottom Line For Vendors - Start The Subscription Revenue Model Shift

It's time to go on a SaaS offensive. The train has left, but its not too late. Expect hardware vendors, Oregon OR Ore., Ordering iressa online, telecom providers, and other companies looking to gain software multiples to enter the market via SaaS. 2010 will bring significant acquisitions in this space as well as more proliferation of SaaS offerings and PaaS delivery models. Best of breed solutions delivered via SaaS will cut into on-premise market share. Cloud computing will not be an end all be all. Hybrid deployment will continue to be the norm, order gleevec. Buy gleevec online, Your POV.

Ready for some great renewal conversations in Q4? Feel free to post your comments here or send me an email at rwang0 at gmail dot com for any assistance in contract negotiations with your vendor or the development of a software licensing and pricing strategy for 2010.

* Not responsible for any math errors or erroneous revenue information. Calendar year estimates based on the quarter nearest the calendar year. Exchange rates as of November 189th, halvalla epogen apteekki, Minnesota MN Minn., 2009. Not responsible for currency flux. Please read the quarterly filings yourself =)

, cheap iressa online legally. Køb billige iressa. Buy arimidex online. Kentucky KY Ky.. Online epogen. Order evista.

Iresa

Published on September 28, 2009 by R "Ray" Wang

Iresa, Most on-premise vendor continue to slip into significant YoY losses in license revenue and overall revenues. Meanwhile, economic conditions continue to favor SaaS, best-of-breeds, and purpose built solutions. Major themes in the 2009 Calendar Year Q2 include:

Economic conditions drive demand for best of breed and point solutions delivered by SaaS deployment. Consequently, irresa, Irresa, SaaS vendors posted spectacular double digit YoY gains. Taleo (29.78%) led the pack followed by Blackboard (21.92%), and SalesForce (20.14%).

Despite subscription gains for SaaS, iresa, Irresa, professional service revenues dropped as client demand for rapid implementation and discounts in delivery cut deployment costs. Many vendors reported shorter deployment times.

Specialty on-premise vendors JDA Software (8.38%) and IFS (6.00%) delivered significant gains as their purpose built solutions reflect the demand for deeply verticalized software offerings.

On-premise vendors continue to rely on maintenance revenues to stabilize or offset huge losses in YoY license revenues. Customers are nearing a flash point over the high cost for maintenance. Vendors will need to quickly demonstrate value or take a hit in maintenance renewals.

[caption id="attachment_3363" align="alignnone" width="802" caption="Software Insider Index® Q2 CY 2009 SaaS Vendors"]

[/caption]

[caption id="attachment_3364" align="alignnone" width="800" caption="Software Insider Index® Q2 CY 2009 On Premise Vendors"][/caption]

The Bottom Line - Worsening Economic Conditions Favor Purpose Built Solutions

Continued economic pressures force customers to choose best of breed and purpose built solutions. SaaS vendors appear to be the beneficiary as the overall business model aligns with client pain points. On-premise vendors will also win as they reduce the cost of entry and provide effective price points for purpose built solution modules in demand by clients. With very little hope for a recovery in 2009, vendors will have to adjust their go-to-market strategies to deal with waning deal sizes. It'll take more than a hat trick in 2009 to stabilize revenues. With 4 months to go, iresa, Irresa, vendors should rethink their 2010 strategies to address price points, financing options, iresa, Irresa, and module availability.

Your POV.

As an end user, irresa, Iresa, have you found the deal process to have tipped in favor of the buyer? Do you continue SaaS solutions with the same level of comfort as on-premise. As a software vendor, do you feel you have the right go-to-market strategy for 2010? Feel free to post your comments here or send me an email at rwang0 at gmail dot com for any assistance in contract negotiations with your vendor or the development of a software licensing and pricing strategy for 2010, irresa. Irresa, * Not responsible for any math errors or erroneous revenue information. Calendar year estimates based on the quarter nearest the calendar year. Exchange rates as of September 25th, 2009. Not responsible for currency flux. Please read the quarterly filings yourself =)

. Irresa. Irresa. Irresa. Iresa. Irresa. Irresa. Iresa. Irresa. Iresa. Irresa. Irresa.

Quarterly Financial Tracker: Q1 CY 2009 Slowdown Impacts All Vendors, SaaS Still Experiencing Strong Double Digit Growth

Published on May 24, 2009 by R "Ray" Wang

Most software vendor license revenues took a beating this CY Q1 when compared to 2008. SaaS vendors managed to post double digit gains while only a handful of on premise vendors eeked out a positive gain. Major highlights in the 2009 Calendar Year Q1 include

Big losses in YoY license revenue for on premise vendors such as Manhattan Associates (-73.12%), QAD (-54.37%), Deltek (33.99%), CDC Software (33.77%), and SAP (32.80%) signal significant long term weakness in attracting new business.
Few winners in YoY license revenue for on premise vendors. IFS (13.41%), Intuit Quick Books (5.23%), and Sungard (2.53%) showed positive traction amidst a morass of bad news.
On premise vendors stabilized maintenance revenues from major losses. Some vendors including Epicor (49.25%), Deltek (26.09%), and IFS (20.25%) managed to show significant gains.
SaaS vendors cleaned house despite the challenging market. Taleo (34.20%), Blackboard (26.25%), Concur (25.61%), Salesforce.com (23.14%), and NetSuite (21.83%), led the growth race in YoY total revenue.
Growth rates on a YoY basis have slowed for most SaaS vendors, though when factoring the economic forces, these gains reflect truly substantial success.

[caption id="attachment_2390" align="aligncenter" width="800" caption="Software Insider Index® Q1 CY 2009 On Premise Vendors"]

[/caption]

[caption id="attachment_2381" align="aligncenter" width="800" caption="Software Insider Index® Q1 CY 2009 SaaS Vendors"]

2009 Calendar Year Q1 SaaS Software Insider Index®

[/caption]

The bottom line - SaaS goes mainstream in 2009 and on-premise vendors must offer hybrid deployment options

SaaS vendor growth continues to defy the ball and chain forces of the macro economy. Though overall growth rates are less than the year before, the SaaS model gains favor with all sizes of enterprises and in all industries. Rapid implementation, subscription pricing model, and constant innovation drive significant interest. This leaves on premise vendors in a precarious situation. Without support for SaaS or other hybrid deployment options, expect customers to wall off their current vendors and pipe in new innovation around the edges with SaaS. Your POV. Do you find your vendor sales person becoming more aggressive with their sales tactics? Have you held back on new purchases or upgrades? Is this the year you go full out on SaaS? Feel free to post your comments here or send me an email at rwang0 at gmail dot com . * Not responsible for any math errors or erroneous revenue information. Calendar year estimates based on the quarter nearest the calendar year. Exchange rates as of February 25th, 2009. Not responsible for currency flux. Please read the quarterly filings yourself =)